These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34673209)

  • 1. Genetic variants in splicing factor genes and susceptibility to bladder cancer.
    Wang X; Guo Z; Zhu H; Xin J; Yuan L; Qin C; Wang M; Zhang Z; Wang Y; Chu H
    Gene; 2022 Jan; 809():146022. PubMed ID: 34673209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing related genetic variants contribute to bladder cancer risk.
    Guo Z; Zhu H; Xu W; Wang X; Liu H; Wu Y; Wang M; Chu H; Zhang Z
    Mol Carcinog; 2020 Aug; 59(8):923-929. PubMed ID: 32339354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations in Hippo pathway genes influence bladder cancer risk in a Chinese population.
    Huang Z; Wang X; Ma L; Guo Z; Liu H; Du M; Chu H; Wang M; Wang Z; Zhang Z
    Arch Toxicol; 2020 Mar; 94(3):785-794. PubMed ID: 32123962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subphenotype meta-analysis of testicular cancer genome-wide association study data suggests a role for RBFOX family genes in cryptorchidism susceptibility.
    Wang Y; Gray DR; Robbins AK; Crowgey EL; Chanock SJ; Greene MH; McGlynn KA; Nathanson K; Turnbull C; Wang Z; Devoto M; Barthold JS;
    Hum Reprod; 2018 May; 33(5):967-977. PubMed ID: 29618007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in N6-methyladenosine are associated with bladder cancer risk in the Chinese population.
    Liu H; Gu J; Jin Y; Yuan Q; Ma G; Du M; Ge Y; Qin C; Lv Q; Fu G; Wang M; Chu H; Yuan L; Zhang Z
    Arch Toxicol; 2021 Jan; 95(1):299-309. PubMed ID: 32964246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in choline metabolism pathway are associated with the risk of bladder cancer in the Chinese population.
    Han Z; Gu J; Xin J; Liu H; Wu Y; Du M; Chu H; Liu Y; Zhang Z
    Arch Toxicol; 2022 Jun; 96(6):1729-1737. PubMed ID: 35237847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population.
    Zhang Y; Sun Y; Chen T; Hu H; Xie W; Qiao Z; Ding N; Xie L; Li S; Wang W; Xing C; Wang Y; Qie Y; Wu C
    Int J Mol Sci; 2014 Oct; 15(11):19330-41. PubMed ID: 25347272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YTHDC1 gene polymorphisms and hepatoblastoma susceptibility in Chinese children: A seven-center case-control study.
    Chen H; Li Y; Li L; Zhu J; Yang Z; Zhang J; Li S; Xin Y; Xia H; He J
    J Gene Med; 2020 Nov; 22(11):e3249. PubMed ID: 32729171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional variants of RPS6KB1 and PIK3R1 in the autophagy pathway genes and risk of bladder cancer.
    Ma L; Zhang D; Huang Z; Zheng R; Du M; Lv Q; Qin C; Chu H; Yuan L; Zhang Z
    Arch Toxicol; 2022 Jan; 96(1):367-375. PubMed ID: 34668023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of rs710886 in lncRNA PCAT1 with bladder cancer risk in a Chinese population.
    Lin Y; Ge Y; Wang Y; Ma G; Wang X; Liu H; Wang M; Zhang Z; Chu H
    Gene; 2017 Sep; 627():226-232. PubMed ID: 28627442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of rs8444 polymorphism in the LASS2 3'-UTR and bladder cancer risk in Chinese population.
    Huang Y; Wang H; Fu S; Luan T; Zuo Y; Li N; Ding M; Chen Y; Wang J
    Eur J Cancer Prev; 2020 Jul; 29(4):329-337. PubMed ID: 31577563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.
    Li P; Gu J; Yang X; Cai H; Tao J; Yang X; Lu Q; Wang Z; Yin C; Gu M
    PLoS One; 2013; 8(8):e71604. PubMed ID: 23977085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
    Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
    Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA BCLET variant confers bladder cancer susceptibility through alternative splicing of MSANTD2 exon 1.
    Liu H; Wang X; Guo Z; Sun G; Lv Q; Qin C; Yuan L; Wang Y; Du M; Wang M; Zhang Z; Chu H
    Cancer Med; 2023 Jul; 12(13):14440-14451. PubMed ID: 37211917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians.
    Singh V; Jaiswal PK; Mittal RD
    Urol Oncol; 2014 Nov; 32(8):1209-14. PubMed ID: 25218484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKR1C2 genetic variants mediate tobacco carcinogens metabolism involving bladder cancer susceptibility.
    Xiao Y; Shen Y; Song H; Gao F; Mao Z; Lv Q; Qin C; Yuan L; Wu D; Chu H; Wang M; Du M; Zheng R; Zhang Z
    Arch Toxicol; 2024 Jul; 98(7):2269-2279. PubMed ID: 38662237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in alternative splicing associated genes are associated with lung cancer risk in a Chinese population.
    Shen W; Yin R; Wang C; Zhu M; Zhou W; Qin N; Sun J; Liu J; Dong J; Jin G; Ma H; Hu Z; Shen H; Xu L; Dai J
    Lung Cancer; 2015 Sep; 89(3):238-42. PubMed ID: 26162562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in RBFOX3 are associated with sleep latency.
    Amin N; Allebrandt KV; van der Spek A; Müller-Myhsok B; Hek K; Teder-Laving M; Hayward C; Esko T; van Mill JG; Mbarek H; Watson NF; Melville SA; Del Greco FM; Byrne EM; Oole E; Kolcic I; Chen TH; Evans DS; Coresh J; Vogelzangs N; Karjalainen J; Willemsen G; Gharib SA; Zgaga L; Mihailov E; Stone KL; Campbell H; Brouwer RW; Demirkan A; Isaacs A; Dogas Z; Marciante KD; Campbell S; Borovecki F; Luik AI; Li M; Hottenga JJ; Huffman JE; van den Hout MC; Cummings SR; Aulchenko YS; Gehrman PR; Uitterlinden AG; Wichmann HE; Müller-Nurasyid M; Fehrmann RS; Montgomery GW; Hofman A; Kao WH; Oostra BA; Wright AF; Vink JM; Wilson JF; Pramstaller PP; Hicks AA; Polasek O; Punjabi NM; Redline S; Psaty BM; Heath AC; Merrow M; Tranah GJ; Gottlieb DJ; Boomsma DI; Martin NG; Rudan I; Tiemeier H; van IJcken WF; Penninx BW; Metspalu A; Meitinger T; Franke L; Roenneberg T; van Duijn CM
    Eur J Hum Genet; 2016 Oct; 24(10):1488-95. PubMed ID: 27142678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer.
    Wang M; Chu H; Lv Q; Wang L; Yuan L; Fu G; Tong N; Qin C; Yin C; Zhang Z; Xu J
    Int J Cancer; 2014 Dec; 135(11):2653-60. PubMed ID: 24740636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population.
    Wang M; Zhang Z; Zhu H; Fu G; Wang S; Wu D; Zhou J; Wei Q; Zhang Z
    Clin Cancer Res; 2008 Jun; 14(11):3633-40. PubMed ID: 18519798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.